These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 17575241)
21. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy. McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955 [TBL] [Abstract][Full Text] [Related]
22. [Genetic polymorphism in cytochrome P450 2E1, salted food and colorectal cancer susceptibility: a case-control study]. Yu WP; Chen K; Ma XY; Yao KY; Jiang QT; Zou Y; Zhou HG Zhonghua Yu Fang Yi Xue Za Zhi; 2004 May; 38(3):162-6. PubMed ID: 15182482 [TBL] [Abstract][Full Text] [Related]
23. Inflammation-related gene polymorphisms and colorectal adenoma. Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170 [TBL] [Abstract][Full Text] [Related]
24. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population. Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937 [TBL] [Abstract][Full Text] [Related]
25. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies. Gu D; Wang M; Wang M; Zhang Z; Chen J Mutagenesis; 2009 Nov; 24(6):507-12. PubMed ID: 19762350 [TBL] [Abstract][Full Text] [Related]
26. TGFBR1*6A polymorphism in sporadic and familial colorectal Carcinoma: a case-control study and systematic literature review. Ibrahim T; Yazbeck C; Maalouly G; Baz M; Haddad F; Sabbagh C; Chahine G J Gastrointest Cancer; 2014 Dec; 45(4):441-7. PubMed ID: 24880985 [TBL] [Abstract][Full Text] [Related]
27. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer? Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982 [TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction? Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940 [TBL] [Abstract][Full Text] [Related]
29. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer]. Wang AZ; Zhu ZZ; Cong WM Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238 [TBL] [Abstract][Full Text] [Related]
30. Association between TGFBR1*6A and cancer: is there any evidence? Lai R J Clin Oncol; 2004 Jul; 22(13):2754; author reply 2754-5. PubMed ID: 15226351 [No Abstract] [Full Text] [Related]
31. APC E1317Q is not associated with Colorectal Cancer in a population-based case-control study in Northern Israel. Rozek LS; Rennert G; Gruber SB Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2325-7. PubMed ID: 17119068 [TBL] [Abstract][Full Text] [Related]
32. Association of an exon 1 polymorphism in the IGFBP3 gene with circulating IGFBP-3 levels and colorectal cancer risk: the multiethnic cohort study. Le Marchand L; Kolonel LN; Henderson BE; Wilkens LR Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1319-21. PubMed ID: 15894694 [TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: a population-based case-control study in China. Zhang Y; Liu B; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K Cancer Lett; 2009 Mar; 275(1):102-8. PubMed ID: 19036501 [TBL] [Abstract][Full Text] [Related]
34. Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study. Hu YS; Pan Y; Li WH; Zhang Y; Li J; Ma BA BMC Cancer; 2010 Apr; 10():169. PubMed ID: 20429896 [TBL] [Abstract][Full Text] [Related]
35. Case-control, kin-cohort and meta-analyses provide no support for STK15 F31I as a low penetrance colorectal cancer allele. Webb EL; Rudd MF; Houlston RS Br J Cancer; 2006 Oct; 95(8):1047-9. PubMed ID: 17003782 [TBL] [Abstract][Full Text] [Related]
36. Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies. Wang YQ; Qi XW; Wang F; Jiang J; Guo QN PLoS One; 2012; 7(8):e42899. PubMed ID: 22905183 [TBL] [Abstract][Full Text] [Related]
37. A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk. Rokavec M; Justenhoven C; Schroth W; Istrate MA; Haas S; Fischer HP; Vollmert C; Illig T; Hamann U; Ko YD; Glavac D; Brauch H Clin Cancer Res; 2007 Dec; 13(24):7506-14. PubMed ID: 18094435 [TBL] [Abstract][Full Text] [Related]
38. [Application of multifactor dimensionality reduction on the interactions between gene-gene, gene-environment and the risk sporadic colorectal cancer in Chinese population]. Jin MJ; Liu B; Zhang SS; Zhang YJ; Xu M; Ma XY; Yao KY; Chen K Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):535-9. PubMed ID: 19040031 [TBL] [Abstract][Full Text] [Related]
39. Genetic variations in the TGFβ signaling pathway, smoking and risk of colorectal cancer in a Chinese population. Zhong R; Liu L; Zou L; Sheng W; Zhu B; Xiang H; Chen W; Chen J; Rui R; Zheng X; Yin J; Duan S; Yang B; Sun J; Lou J; Liu L; Xie D; Xu Y; Nie S; Miao X Carcinogenesis; 2013 Apr; 34(4):936-42. PubMed ID: 23275154 [TBL] [Abstract][Full Text] [Related]
40. Heterozygosity for interleukin-18 -607 A/C polymorphism is associated with risk for colorectal cancer. Nikiteas N; Yannopoulos A; Chatzitheofylaktou A; Tsigris C Anticancer Res; 2007; 27(6B):3849-53. PubMed ID: 18225542 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]